Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Jarius, Sven [VerfasserIn]   i
 Probst, C. [VerfasserIn]   i
 Borowski, K. [VerfasserIn]   i
 Franciotta, D. [VerfasserIn]   i
 Wildemann, Brigitte [VerfasserIn]   i
 Stoecker, W. [VerfasserIn]   i
 Wandinger, K. P. [VerfasserIn]   i
Titel:Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen
Verf.angabe:S. Jarius, C. Probst, K. Borowski, D. Franciotta, B. Wildemann, W. Stoecker, K.P. Wandinger
E-Jahr:2010
Jahr:[15 April 2010]
Umfang:5 S.
Illustrationen:Illustrationen
Fussnoten:Available online 1 February 2010 ; Gesehen am 18.07.2023
Titel Quelle:Enthalten in: Journal of the neurological sciences
Ort Quelle:Amsterdam [u.a.] : Elsevier Science, 1964
Jahr Quelle:2010
Band/Heft Quelle:291(2010), 1 vom: Apr., Seite 52-56
ISSN Quelle:1878-5883
Abstract:Background - Recently, a highly specific serum autoantibody was discovered in patients with neuromyelitis optica, called NMO-IgG, and aquaporin-4, the most abundant water channel in the CNS, was identified as the target antigen. Several assays for the detection of NMO-IgG/AQP4-Ab have been described. Tests based on recombinant human AQP4 have been repeatedly demonstrated to be more sensitive than the previous gold standard assay, i.e. immunohistochemistry (IHC) on mouse brain tissue. However, the sophisticated techniques applied restrict their availability to few laboratories worldwide. - Objective - To develop an easy-to-use, recombinant immunofluorescence assay (rIFA) suitable for standardized and high-throughput detection of NMO-IgG/AQP4-Ab. - Methods - HEK293 cells seeded on cover glasses were transfected with full-length recombinant human AQP4 at large scale. Cover glasses with the immobilized cells were cut into millimetre-sized fragments and transferred to microscopy slides. 151 serum samples from patients with NMO spectrum disorders (NMOSD) and controls were analysed both in the standard IHC assay and in the newly developed rIFA. - Results - 25/32 (78.1%) patients with clinically definite NMO and 36/51 (70.6%) of total patients with NMOSD were positive for NMO-IgG/AQP4-Ab in the rIFA compared to 65.6% and 58.8%, respectively, in the IHC assay. - Conclusion - The recombinant IFA presented here provides laboratories familiar with indirect immunofluorescence microscopy with a highly sensitive and reproducible diagnostic tool for standardized detection of antibodies to AQP4. This new approach could make AQP4-Ab testing, which is of high clinical relevance, more widely available.
DOI:doi:10.1016/j.jns.2010.01.002
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1016/j.jns.2010.01.002
 Volltext: https://www.sciencedirect.com/science/article/pii/S0022510X10000109
 DOI: https://doi.org/10.1016/j.jns.2010.01.002
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Antibody to aquaporin-4
 Diagnosis
 Immunofluorescence assay
 Longitudinally extensive transverse myelitis
 Multiple sclerosis
 Neuromyelitis optica (Devic syndrome)
 NMO-IgG
 Optic neuritis
 Recombinant antigen
K10plus-PPN:185294742X
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69099027   QR-Code
zum Seitenanfang